trending Market Intelligence /marketintelligence/en/news-insights/trending/lhjz1lzejwrfwaejch6sjq2 content esgSubNav
In This List

Advaxis prices public offering to raise $20M

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Advaxis prices public offering to raise $20M

Advaxis, Inc. priced a public announced offering of 10 million shares at $2 each to raise $20 million.

Advaxis plans to use net proceeds to fund the development of its product pipeline.

Jefferies and Guggenheim Securities are acting as joint book-running managers for the offering. The underwriters have an option to purchase up to an additional 807,697 shares.

The Princeton, N.J.- based biotechnology company expects to close the offering by Feb. 26.